Exercise testing identifies high-risk silent ischaemia
This article was originally published in Clinica
Executive Summary
A Finnish study has highlighted the importance of exercise testing as a means of predicting coronary heart disease (CHD) I asymptomatic, high-risk men. In men with increased risk of CHD, such as smokers and hypercholesterolaemic or hypertensive men, the identification of exercise-induced silent myocardial ischaemia is of significant additional prognostic value, researchers report in the Journal of the American College of Cardiology (July).
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.